[Towards the optimal management in 2004 of patients with stable coronary artery disease].
Solignac
Marie
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy*; D005060:Europe; D006801:Humans; D009204:Myocardial Revascularization; D020913:Perindopril / Q000627:therapeutic use*; D011379:Prognosis; D016896:Treatment Outcome; D020257:Ventricular Remodeling
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D020913:Perindopril